Generex Biotechnology and Pevion Biotech announce plans for immunotherapeutic vaccine collaboration.
WORCESTER, MA, December 16, 2008 (GlobeNewswire) – Generex Biotechnology Corporation (NasdaqCM:GNBT, www.generex.com) and Pevion Biotech Ltd. (www.pevion.com) have signed an agreement to work together to develop next-generation vaccines and immunotherapeutic products.
